Tag Archives: Trikafta®

New FDA-approved cystic fibrosis medicine, Trikafta®, among other specialty drugs available through AllianceRx Walgreens Prime – BioSpace

  ORLANDO, Fla., Jan. 6, 2020 /PRNewswire/ — AllianceRx Walgreens Prime, one of the largest specialty and home delivery pharmacies in the U.S., is pleased to include Trikafta® (elexacaftor/tezacaftor/ivacaftor and ivacaftor), a new breakthrough therapy for cystic fibrosis (CF), among other specialty medications available through its pharmacy. Cystic fibrosis is a rare, progressive, life-threatening disease… Read More »